Delivery Order SPE2DX15D6028-SPE2DX24FWPMP
Award Date
6/5/24
Potential Completion Date
7/3/24
Potential Value
$3.8K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,150.76 Firm Fixed Price Delivery Order covers the supply of Quillivant XR 25 mg/5 ml suspension medication with a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,607.38, is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) for pharmaceutical products and medical supplies. The contract covers the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a medication, to support military healthcare programs. The contract has no set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,508.50 delivery order is for Quillivant XR, a 25 mg/5 ml suspension medication, with a completion date of June 24, 2022. The contract is a firm fixed-price arrangement and was not subject to any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.36 delivery order covers the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for treating certain medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,344.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a vehicle for the company to supply a broad range of pharmaceutical products and...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00 through December 31, 2025, is the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Quillivant XR (25 mg/5 ml suspension, 60 ml) on a firm-fixed price basis. The $1,016.24 delivery order contract has a period of performance through September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,609.81 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.46 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,013.72 to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the requested medication to the government. This...